SEC Form 4 · accession 0001225208-18-012713
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Bobo Jr.
Officer — CVP,Strategy/Corp Development
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2018 | M | 5,500 | $42.725 | A | 25,565 | D | |
| Common Stock | Aug 15, 2018 | S | 5,500 | $136.73 | D | 20,065 | D | |
| Common StockF2 | holding | — | — | — | 12,550 | I | 401(k) | |
| Common Stock | holding | — | — | — | 50,785 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $42.725 | Aug 15, 2018 | M | 5,500 | D | May 9, 2012 | May 8, 2019 | Common Stock | 5,500 | 39,100 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018.
- F2Includes an additional 5.6596 shares that reflect an increase in Issuer's match pursuant to a recent plan amendment.
Remarks
This form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.